Clarivate Report Explores Opportunities for Innovation and Market Expansion in Latin America
Clarivate (NYSE: CLVT) has published a white paper analyzing the pharmaceutical industry's growth potential in Latin America. The report, titled 'How is Latin America Growing?', highlights that the region's pharmaceutical market, valued at $98 billion, is projected to grow by 10.1% between 2021 and 2025.
The study emphasizes key areas for development including strategic partnerships, local API production, and regulatory modernization. Insights were gathered from discussions at the 2023 Summit LATAM in Barcelona and 2024 Summit LATAM at CPhI Milan, focusing on collaboration between industry stakeholders, government agencies, and academia.
The report outlines critical findings including: the need for transparency in partnerships, potential of local API production to reduce import dependence, AI's role in modernizing regulatory processes, and importance of consistent policies for investment and innovation.
Clarivate (NYSE: CLVT) ha pubblicato un documento bianco che analizza il potenziale di crescita dell'industria farmaceutica in America Latina. Il rapporto, intitolato 'Come sta crescendo l'America Latina?', evidenzia che il mercato farmaceutico della regione, valutato 98 miliardi di dollari, è previsto crescere del 10,1% tra il 2021 e il 2025.
Lo studio sottolinea aree chiave per lo sviluppo, tra cui partnership strategiche, produzione locale di principi attivi (API) e modernizzazione normativa. Le informazioni sono state raccolte da discussioni al Summit LATAM 2023 a Barcellona e al Summit LATAM 2024 a CPhI Milano, con focus sulla collaborazione tra attori dell'industria, agenzie governative e accademia.
Il rapporto delinea risultati critici, tra cui: la necessità di trasparenza nelle partnership, il potenziale della produzione locale di API per ridurre la dipendenza dalle importazioni, il ruolo dell'IA nella modernizzazione dei processi normativi e l'importanza di politiche coerenti per investimenti e innovazione.
Clarivate (NYSE: CLVT) ha publicado un documento técnico que analiza el potencial de crecimiento de la industria farmacéutica en América Latina. El informe, titulado '¿Cómo está creciendo América Latina?', destaca que el mercado farmacéutico de la región, valorado en 98 mil millones de dólares, se proyecta que crecerá un 10.1% entre 2021 y 2025.
El estudio enfatiza áreas clave para el desarrollo, incluyendo asociaciones estratégicas, producción local de principios activos (API) y modernización regulatoria. Se recopilaron ideas de discusiones en la Cumbre LATAM 2023 en Barcelona y la Cumbre LATAM 2024 en CPhI Milán, centrándose en la colaboración entre los actores de la industria, agencias gubernamentales y la academia.
El informe describe hallazgos críticos, incluyendo: la necesidad de transparencia en las asociaciones, el potencial de la producción local de API para reducir la dependencia de las importaciones, el papel de la IA en la modernización de los procesos regulatorios y la importancia de políticas consistentes para la inversión y la innovación.
Clarivate (NYSE: CLVT)는 라틴 아메리카의 제약 산업 성장 잠재력을 분석한 백서를 발표했습니다. '라틴 아메리카는 어떻게 성장하고 있는가?'라는 제목의 보고서는 이 지역의 제약 시장이 980억 달러로 평가되며 2021년부터 2025년까지 10.1% 성장할 것으로 예상된다고 강조합니다.
이 연구는 전략적 파트너십, 현지 API 생산 및 규제 현대화와 같은 개발의 주요 분야를 강조합니다. 2023년 바르셀로나에서 열린 LATAM 정상 회담과 2024년 밀라노 CPhI에서 열린 LATAM 정상 회담에서 산업 이해관계자, 정부 기관 및 학계 간의 협력에 대한 논의에서 통찰력을 얻었습니다.
보고서는 파트너십의 투명성 필요성, 수입 의존도를 줄이기 위한 현지 API 생산의 잠재력, 규제 프로세스 현대화에서 AI의 역할, 투자 및 혁신을 위한 일관된 정책의 중요성과 같은 중요한 발견을 설명합니다.
Clarivate (NYSE: CLVT) a publié un document blanc analysant le potentiel de croissance de l'industrie pharmaceutique en Amérique Latine. Le rapport, intitulé 'Comment l'Amérique Latine grandit-elle ?', souligne que le marché pharmaceutique de la région, évalué à 98 milliards de dollars, devrait croître de 10,1% entre 2021 et 2025.
L'étude met en avant des domaines clés pour le développement, notamment des partenariats stratégiques, la production locale de principes actifs (API) et la modernisation des réglementations. Les informations ont été recueillies lors des discussions au Sommet LATAM 2023 à Barcelone et au Sommet LATAM 2024 à CPhI Milan, en mettant l'accent sur la collaboration entre les acteurs de l'industrie, les agences gouvernementales et le monde académique.
Le rapport décrit des conclusions critiques, notamment : la nécessité de transparence dans les partenariats, le potentiel de la production locale d'API pour réduire la dépendance aux importations, le rôle de l'IA dans la modernisation des processus réglementaires et l'importance de politiques cohérentes pour l'investissement et l'innovation.
Clarivate (NYSE: CLVT) hat ein Weißbuch veröffentlicht, das das Wachstumspotenzial der Pharmaindustrie in Lateinamerika analysiert. Der Bericht mit dem Titel 'Wie wächst Lateinamerika?' hebt hervor, dass der Pharma-Markt der Region, der auf 98 Milliarden Dollar geschätzt wird, zwischen 2021 und 2025 voraussichtlich um 10,1% wachsen wird.
Die Studie betont Schlüsselbereiche für die Entwicklung, darunter strategische Partnerschaften, lokale API-Produktion und die Modernisierung von Vorschriften. Die Erkenntnisse wurden aus Diskussionen beim LATAM-Gipfel 2023 in Barcelona und dem LATAM-Gipfel 2024 bei CPhI in Mailand gewonnen, wobei der Schwerpunkt auf der Zusammenarbeit zwischen Akteuren der Industrie, Regierungsbehörden und der Wissenschaft lag.
Der Bericht skizziert wichtige Ergebnisse, darunter: die Notwendigkeit von Transparenz in Partnerschaften, das Potenzial der lokalen API-Produktion zur Verringerung der Importabhängigkeit, die Rolle von KI bei der Modernisierung von Regulierungsprozessen und die Bedeutung konsistenter Politiken für Investitionen und Innovation.
- Strong market growth projection of 10.1% (2021-2025)
- Large market size of $98 billion
- Strategic expansion into growing Latin American market
- Heavy reliance on pharmaceutical imports
- Regulatory challenges requiring modernization
- Need for infrastructure development in API production
New insights from Clarivate examine strategic partnerships, API production, and innovation in the region
Henry Levy, President, Life Sciences and Healthcare, Clarivate, said: "The Latin American pharmaceutical sector is at a pivotal moment. By fostering collaboration across key stakeholders—including regulators, manufacturers, and researchers—we can unlock new opportunities for growth and development in the region. Strengthening the local pharmaceutical ecosystem through strategic partnerships and data-driven insights will not only enhance supply chain resilience but also ensure that life-changing therapies reach patients more efficiently. At Clarivate, we are committed to providing the necessary intelligence to support this transformation."
The Brazilian Pharmaceutical Industry Association (ABIQUIFI), a non-profit organization uniting pharmaceutical companies to advance the development and production of pharmaceutical ingredients in
The report highlights key findings from recent discussions, including:
- The need for greater transparency and collaboration in strategic partnerships
- The potential of local API production to reduce reliance on imports and enhance supply chain security
- The role of artificial intelligence in modernizing regulatory processes and improving efficiency
- The importance of consistent, long-term policies to encourage investment and innovation
Clarivate remains committed to supporting the region's life sciences and healthcare sectors by providing reliable, data-driven insights. By fostering industry-wide dialogue and collaboration, the company aims to contribute to an ecosystem of sustainable innovation in
To access the full Clarivate report, How is Latin America Growing?, visit here.
To learn more about how Clarivate can help healthcare companies inform and shape the drug discovery, development and delivery process, visit here.
About Clarivate
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com
Media Contact:
Catherine Daniel
Director External Communications, Life Sciences & Healthcare, Clarivate
newsroom@clarivate.com
1 Source: InFigures:
View original content to download multimedia:https://www.prnewswire.com/news-releases/clarivate-report-explores-opportunities-for-innovation-and-market-expansion-in-latin-america-302386521.html
SOURCE Clarivate Plc
FAQ
What is the projected growth rate for Latin America's pharmaceutical market according to Clarivate's report?
How large is the current Latin American pharmaceutical market value discussed in CLVT's report?
What are the main focus areas identified in Clarivate's Latin America pharmaceutical report?
Which industry events contributed to the insights in CLVT's Latin America pharmaceutical report?
